In 2022, chronic lower respiratory disease was the sixth highest cause of death in the U.S., according to results published ...

Researchers developed a new COPD-ES questionnaire for healthcare professionals to improve the management of stable chronic ...

Qureight Ltd and Avalyn Pharma Inc have announced a strategic partnership in progressive pulmonary fibrosis (PPF). The ...

Among adults hospitalized with influenza, Tamiflu treatment on the day of hospital admission was associated with a reduced risk for disease progression.

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

The following is a summary of “Feasibility, Usability, and Pilot Efficacy Study of a Software-Enabled, Virtual Pulmonary ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology ...

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

Announcing a new article publication for Zoonoses journal. This study was aimed at exploring pulmonary tuberculosis (PTB) epidemiological characteristics and trends in China from 2016 to 2022, to ...

Harvard Health explains: "Power naps allow your body and mind to rest without entering deeper stages of sleep. Once you enter ...

Learn more about whether Amedisys, Inc. or The Ensign Group, Inc. is a better investment based on AAII's A+ Investor grades, ...

Long-term exposure to PM2.5, PM10, NO2 and ozone (O3) air pollution is associated with more hospital admissions for lower respiratory tract infections in adults.